Home › Asset managers › ProShares › 2025-2026 › Against the board
Two kinds of vote are listed: a board-sponsored proposal ProShares voted AGAINST or withheld on, and a shareholder proposal it voted FOR. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
2,976 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | ProShares voted | Funds |
|---|---|---|---|---|---|---|
| Chewy, Inc. | 2025-07-10 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 10 |
| Chewy, Inc. | 2025-07-10 | To elect to the Board of Directors four director nominees for three-year terms: David Leland | Director Elections | Board | ABSTAIN | 10 |
| Chewy, Inc. | 2025-07-10 | To elect to the Board of Directors four director nominees for three-year terms: Lisa Sibenac | Director Elections | Board | ABSTAIN | 10 |
| Chewy, Inc. | 2025-07-10 | To elect to the Board of Directors four director nominees for three-year terms: Mathieu Bigand | Director Elections | Board | ABSTAIN | 10 |
| Chewy, Inc. | 2025-07-10 | To elect to the Board of Directors four director nominees for three-year terms: Sumit Singh | Director Elections | Board | ABSTAIN | 10 |
| Cipher Digital Inc. | 2026-06-02 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 10 |
| Cipher Digital Inc. | 2026-06-02 | Election of Directors: Wesley Williams | Director Elections | Board | ABSTAIN | 10 |
| Coherus Oncology, Inc. | 2026-05-29 | To approve a reduction in the exercise price of certain outstanding stock options. | Compensation | Board | AGAINST | 10 |
| Coherus Oncology, Inc. | 2026-05-29 | To approve an increase in the number of shares of our common stock reserved for issuance under the Amended and Restated 2014 Equity Incentive Award Plan. | Compensation | Board | AGAINST | 10 |
| Comerica Incorporated | 2026-01-06 | Proposal to approve, on an advisory (non-binding) basis, the merger-related compensation payments that will or may be paid to Comerica's named executive officers in connection with the first merger. | Say-on-Pay | Board | AGAINST | 10 |
| Consolidated Water Co. Ltd. | 2026-06-01 | The approval of the Company's 2027 Employee Stock Incentive Plan. | Compensation | Board | AGAINST | 10 |
| Core Scientific, Inc. | 2026-05-12 | Election of Directors: Eric Weiss | Director Elections | Board | ABSTAIN | 10 |
| Core Scientific, Inc. | 2026-05-12 | Election of Directors: Jeff Booth | Director Elections | Board | ABSTAIN | 10 |
| Core Scientific, Inc. | 2026-05-12 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 10 |
| Design Therapeutics, Inc. | 2026-06-09 | To elect one nominee for Class II director named herein to serve for a three-year term until the 2029 Annual Meeting of Stockholders: Simeon George, M.D. | Director Elections | Board | ABSTAIN | 10 |
| DigitalBridge Group, Inc. | 2026-04-23 | To approve, on a non-binding, advisory basis, certain compensation that will or may be paid by DigitalBridge to its named executive officers that is based on or otherwise relates to the mergers. | Say-on-Pay | Board | AGAINST | 10 |
| DigitalBridge Group, Inc. | 2026-05-28 | To approve, on a non-binding, advisory basis, named executive officer compensation | Say-on-Pay | Board | AGAINST | 10 |
| Donegal Group Inc. | 2026-04-16 | Election of Directors Nominees for Class A Directors: Annette B. Szady | Director Elections | Board | ABSTAIN | 10 |
| Donegal Group Inc. | 2026-04-16 | Election of Directors Nominees for Class A Directors: David C. King | Director Elections | Board | ABSTAIN | 10 |
| Donegal Group Inc. | 2026-04-16 | Election of Directors Nominees for Class A Directors: Kevin G. Burke | Director Elections | Board | ABSTAIN | 10 |
| Editas Medicine, Inc. | 2026-06-17 | To approve, on an advisory basis, the compensation paid to the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 10 |
| Enanta Pharmaceuticals, Inc. | 2026-03-11 | To approve an amendment to our 2019 Equity Incentive Plan. | Compensation | Board | AGAINST | 10 |
| Entrada Therapeutics, Inc. | 2026-06-10 | Approval of Amendment No. 1 to the Entrada Therapeutics, Inc. 2021 Employee Stock Purchase Plan. | Compensation | Board | AGAINST | 10 |
| Entrada Therapeutics, Inc. | 2026-06-10 | Approval of Amendment No. 1 to the Entrada Therapeutics, Inc. 2021 Stock Option and Incentive Plan. | Compensation | Board | AGAINST | 10 |
| Entrada Therapeutics, Inc. | 2026-06-10 | Election of Directors: Bernhardt Zeiher, M.D. | Director Elections | Board | ABSTAIN | 10 |
| Entrada Therapeutics, Inc. | 2026-06-10 | Election of Directors: Peter S. Kim, Ph.D. | Director Elections | Board | ABSTAIN | 10 |
| Eos Energy Enterprises, Inc. | 2026-06-03 | Amendment to our Second Amended and Restated 2020 Incentive Plan. | Compensation | Board | AGAINST | 10 |
| Eos Energy Enterprises, Inc. | 2026-06-03 | Election of Directors: Claude Demby | Director Elections | Board | AGAINST | 10 |
| Eos Energy Enterprises, Inc. | 2026-06-03 | Non-binding advisory vote to approve our named executive officer compensation. | Say-on-Pay | Board | AGAINST | 10 |
| Eton Pharmaceuticals, Inc. | 2026-06-09 | Election of Directors: To elect Charles J. Casamento as Class II director to hold office until the 2029 annual meeting of stockholders and until a successor is duly elected and qualified, or until earlier resignation or removal. | Director Elections | Board | ABSTAIN | 10 |
| Eton Pharmaceuticals, Inc. | 2026-06-09 | Election of Directors: To elect Jenn Adams as Class II director to hold office until the 2029 annual meeting of stockholders and until a successor is duly elected and qualified, or until earlier resignation or removal. | Director Elections | Board | ABSTAIN | 10 |
| Evercore Inc. | 2026-06-10 | Approval of the Fourth Amended and Restated 2016 Evercore Inc. Stock Incentive Plan. | Compensation | Board | AGAINST | 10 |
| Evolus, Inc. | 2026-06-11 | Election of Class II directors for a three-year term: Brady Stewart | Director Elections | Board | ABSTAIN | 10 |
| Evolus, Inc. | 2026-06-11 | Election of Class II directors for a three-year term: Vikram Malik | Director Elections | Board | ABSTAIN | 10 |
| Fluence Energy, Inc. | 2026-03-12 | To elect the following twelve (12) directors to hold office until the Company's 2027 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Fahad Al-Darwish | Director Elections | Board | ABSTAIN | 10 |
| Foghorn Therapeutics Inc. | 2026-06-24 | Elect Class III directors each for a three-year term: B. Lynne Parshall | Director Elections | Board | AGAINST | 10 |
| Foghorn Therapeutics Inc. | 2026-06-24 | Elect Class III directors each for a three-year term: Douglas Cole, M.D. | Director Elections | Board | AGAINST | 10 |
| GLOBALFOUNDRIES Inc. | 2025-07-29 | Elect Director Camilla Languille | Director Elections | Board | ABSTAIN | 10 |
| GLOBALFOUNDRIES Inc. | 2025-07-29 | Elect Director Thomas Caulfield | Director Elections | Board | ABSTAIN | 10 |
| GLOBALFOUNDRIES Inc. | 2025-07-29 | Elect Director Tim Breen | Director Elections | Board | ABSTAIN | 10 |
| Genie Energy Ltd. | 2026-06-10 | Election of Directors: Alan Rosenthal | Director Elections | Board | AGAINST | 10 |
| Genie Energy Ltd. | 2026-06-10 | Election of Directors: Howard S. Jonas | Director Elections | Board | AGAINST | 10 |
| Genie Energy Ltd. | 2026-06-10 | Election of Directors: W. Wesley Perry | Director Elections | Board | AGAINST | 10 |
| Genie Energy Ltd. | 2026-06-10 | To approve an amendment to the Genie Energy Ltd. 2021 Stock Option and Incentive Plan that will increase the number of shares of the Company's Class B common stock available for the grant of awards thereunder by 70,000. | Compensation | Board | AGAINST | 10 |
| Gladstone Land Corporation | 2026-05-14 | Election of Directors: John H. Outland | Director Elections | Board | ABSTAIN | 10 |
| Globalstar, Inc. | 2026-05-13 | Approve, on an advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 10 |
| Globalstar, Inc. | 2026-05-13 | Election of Class B Directors: James F. Lynch | Director Elections | Board | ABSTAIN | 10 |
| Globalstar, Inc. | 2026-05-13 | Election of Class B Directors: Timothy E. Taylor | Director Elections | Board | ABSTAIN | 10 |
| Gossamer Bio, Inc. | 2026-06-04 | Election of Class II Directors: Faheem Hasnain | Director Elections | Board | ABSTAIN | 10 |
| Gossamer Bio, Inc. | 2026-06-04 | Election of Class II Directors: Russell Cox | Director Elections | Board | ABSTAIN | 10 |
| Graco Inc. | 2026-04-24 | Approval, on an advisory basis, of the compensation paid to our named executive officers as disclosed in the Proxy Statement. | Say-on-Pay | Board | AGAINST | 10 |
| Humacyte, Inc. | 2026-06-09 | Approval, on an advisory basis, of the compensation paid to Humacyte, Inc.'s named executive officers. | Say-on-Pay | Board | AGAINST | 10 |
| Humacyte, Inc. | 2026-06-09 | Election of three Class II directors to serve until the 2029 annual meeting of stockholders: John P. Bamforth | Director Elections | Board | ABSTAIN | 10 |
| IonQ, Inc. | 2026-06-16 | To approve, on an advisory basis, the compensation of our named executive officers in 2025. | Say-on-Pay | Board | AGAINST | 10 |
| Joby Aviation, Inc. | 2026-06-02 | Election of Directors: To be elected for terms expiring in 2029: Halimah DeLaine Prado | Director Elections | Board | ABSTAIN | 10 |
| Larimar Therapeutics, Inc. | 2026-05-19 | Election of Class III Directors for a Three-Year Term Expiring in 2029: Carole S. Ben-Maimon, M.D. | Director Elections | Board | ABSTAIN | 10 |
| Larimar Therapeutics, Inc. | 2026-05-19 | Election of Class III Directors for a Three-Year Term Expiring in 2029: Frank Thomas | Director Elections | Board | ABSTAIN | 10 |
| Larimar Therapeutics, Inc. | 2026-05-19 | Election of Class III Directors for a Three-Year Term Expiring in 2029: Joseph Truitt | Director Elections | Board | ABSTAIN | 10 |
| Maravai Lifesciences Holdings, Inc. | 2026-05-26 | To elect three nominees to the Board of Directors (3-year term expiring in 2029): Bernd Brust | Director Elections | Board | ABSTAIN | 10 |
| Maravai Lifesciences Holdings, Inc. | 2026-05-26 | To elect three nominees to the Board of Directors (3-year term expiring in 2029): Gregory T. Lucier | Director Elections | Board | ABSTAIN | 10 |
| Maravai Lifesciences Holdings, Inc. | 2026-05-26 | To elect three nominees to the Board of Directors (3-year term expiring in 2029): Luke Marker | Director Elections | Board | ABSTAIN | 10 |
| MeiraGTx Holdings Plc | 2026-06-11 | Election of Directors: Debra Yu, M.D. | Director Elections | Board | ABSTAIN | 10 |
| MercadoLibre, Inc. | 2026-06-09 | Election of Directors: Class I Nominees: Stelleo Passos Tolda | Director Elections | Board | ABSTAIN | 10 |
| Nabors Industries Ltd. | 2026-06-02 | Approval, on a non-binding, advisory basis, of the compensation paid by the Company to its named executive officers. | Say-on-Pay | Board | AGAINST | 10 |
| NovaGold Resources Inc. | 2026-05-14 | Approval of Non-Binding Advisory Vote on Executive Compensation To consider and, if deemed advisable, pass a non-binding resolution approving the compensation of the Company's Named Executive Officers. | Say-on-Pay | Board | AGAINST | 10 |
| NovoCure Limited | 2026-06-03 | The approval of our amended and restated 2024 Omnibus Incentive Plan. | Compensation | Board | AGAINST | 10 |
| OPKO Health, Inc. | 2026-06-18 | To approve the Company's 2026 Equity Incentive Plan; | Compensation | Board | AGAINST | 10 |
| OPKO Health, Inc. | 2026-06-18 | To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Phillip Frost, M.D. | Director Elections | Board | AGAINST | 10 |
| Oil-Dri Corporation of America | 2025-12-09 | Election of Directors: Allan H. Selig | Director Elections | Board | ABSTAIN | 10 |
| Oil-Dri Corporation of America | 2025-12-09 | Election of Directors: Amy L. Ryan | Director Elections | Board | ABSTAIN | 10 |
| Oil-Dri Corporation of America | 2025-12-09 | Election of Directors: Daniel S. Jaffee | Director Elections | Board | ABSTAIN | 10 |
| Oil-Dri Corporation of America | 2025-12-09 | Election of Directors: Ellen-Blair Chube | Director Elections | Board | ABSTAIN | 10 |
| Oil-Dri Corporation of America | 2025-12-09 | Election of Directors: George C. Roeth | Director Elections | Board | ABSTAIN | 10 |
| Oil-Dri Corporation of America | 2025-12-09 | Election of Directors: Lawrence E. Washow | Director Elections | Board | ABSTAIN | 10 |
| Oil-Dri Corporation of America | 2025-12-09 | Election of Directors: Michael A. Nemeroff | Director Elections | Board | ABSTAIN | 10 |
| Oil-Dri Corporation of America | 2025-12-09 | Election of Directors: Patricia J. Schmeda | Director Elections | Board | ABSTAIN | 10 |
| Oil-Dri Corporation of America | 2025-12-09 | Election of Directors: Paul M. Hindsley | Director Elections | Board | ABSTAIN | 10 |
| Ouster, Inc. | 2026-06-17 | Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 10 |
| Ouster, Inc. | 2026-06-17 | Election of Class II Directors: Angus Pacala | Director Elections | Board | ABSTAIN | 10 |
| Pacific Biosciences of California, Inc. | 2026-06-03 | To approve the amendment of our 2020 Equity Incentive Plan. | Compensation | Board | AGAINST | 10 |
| Pacific Biosciences of California, Inc. | 2026-06-03 | To approve, on an advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 10 |
| Peloton Interactive, Inc. | 2025-12-09 | Election of Directors: Chris Bruzzo | Director Elections | Board | ABSTAIN | 10 |
| Personalis, Inc. | 2026-05-12 | Election of Directors: Woodrow A. Myers, Jr., M.D. | Director Elections | Board | ABSTAIN | 10 |
| Petco Health and Wellness Company, Inc. | 2026-06-30 | To approve the Second Amendment to the Company's 2021 Equity Incentive Plan to increase the number of shares of Class A Common Stock authorized for issuance under the plan. | Compensation | Board | AGAINST | 10 |
| Petco Health and Wellness Company, Inc. | 2026-06-30 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 10 |
| Petco Health and Wellness Company, Inc. | 2026-06-30 | To elect the four director nominees named in the proxy statement as Class III directors of the Company, each to serve for a three-year term and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, removal, retirement or disqualification: Joel Anderson | Director Elections | Board | AGAINST | 10 |
| Plug Power Inc. | 2026-06-11 | The approval of the non-binding, advisory vote regarding the compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 10 |
| Prime Medicine, Inc. | 2025-08-01 | To approve the repricing of certain outstanding stock options that have been granted under the Company's 2019 Stock Option and Grant Plan and/or the 2022 Stock Option and Incentive Plan (the "Option Repricing Proposal"). | Compensation | Board | AGAINST | 10 |
| Puma Biotechnology, Inc. | 2026-06-11 | Approve an amendment to extend the expiration date until October 4, 2028 of a warrant held by Alan H. Auerbach, as described in the proxy statement. | Capital Structure | Board | AGAINST | 10 |
| Quantum-Si Incorporated | 2026-05-15 | To approve, by a non-binding, advisory vote, the compensation of our named executive officers, as disclosed in this proxy statement | Say-on-Pay | Board | AGAINST | 10 |
| Quantum-Si Incorporated | 2026-05-15 | To elect ten directors to serve one-year terms expiring in 2027: Jack Kenny | Director Elections | Board | AGAINST | 10 |
| RenaissanceRe Holdings Ltd. | 2026-05-05 | To approve the RenaissanceRe Holdings Ltd. 2026 Long-Term Incentive Plan. | Compensation | Board | AGAINST | 10 |
| Rigetti Computing, Inc. | 2026-06-09 | To elect one Class I director to hold office until the 2029 Annual Meeting of Stockholders: Dr. Subodh Kulkarni | Director Elections | Board | ABSTAIN | 10 |
| Roivant Sciences Ltd. | 2025-09-10 | To cast a non-binding, advisory vote to approve the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 10 |
| Roivant Sciences Ltd. | 2025-09-10 | To elect the Board of Directors' three nominees for Class I Director to serve for a three-year term: Matthew Gline | Director Elections | Board | ABSTAIN | 10 |
| SIGA Technologies, Inc. | 2026-06-09 | To approve an amendment to the SIGA Technologies, Inc. Amended and Restated 2010 Stock Incentive Plan to increase the number of shares of common stock available for issuance. | Compensation | Board | AGAINST | 10 |
| Service Corporation International | 2026-05-06 | Election of Directors: Marcus A. Watts | Director Elections | Board | AGAINST | 10 |
| Service Corporation International | 2026-05-06 | To approve the 2026 Equity Incentive Plan. | Compensation | Board | AGAINST | 10 |
| Shoals Technologies Group, Inc. | 2026-04-30 | Approval, by an advisory vote, of the compensation of the Company's Named Executive Officers (i.e., "say-on-pay proposal). | Say-on-Pay | Board | AGAINST | 10 |
| Shoals Technologies Group, Inc. | 2026-04-30 | Election of Director Nominees: Jeannette Mills | Director Elections | Board | ABSTAIN | 10 |
← Previous Page 8 of 30 Next →
← Back to ProShares 2025-2026 overview
Built 2026-10-04 from SEC Form N-PX filings.